Methantheline bromide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methantheline bromide and what is the scope of patent protection?
Methantheline bromide
is the generic ingredient in one branded drug marketed by Shire and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for methantheline bromide
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 1 |
Patent Applications: | 714 |
Formulation / Manufacturing: | see details |
DailyMed Link: | methantheline bromide at DailyMed |
Recent Clinical Trials for methantheline bromide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
RIEMSER Arzneimittel GmbH | Phase 1 |
University Medicine Greifswald | Phase 1 |
US Patents and Regulatory Information for methantheline bromide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shire | BANTHINE | methantheline bromide | TABLET;ORAL | 007390-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |